Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A or B”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Not applicableStudy completedNCT02740413
What this trial is testing

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Who this might be right for
Hemophilia AHemophilia B
Pfizer 86
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Early research (Phase 1)Study completedNCT01439971
What this trial is testing

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Who this might be right for
Hemophilia A
Catalyst Biosciences 29
Large-scale testing (Phase 3)Study completedNCT01625390
What this trial is testing

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

Who this might be right for
Hemophilia A, Hemophilia B
Bayer 10
Large-scale testing (Phase 3)Ended earlyNCT04489537
What this trial is testing

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 18
Post-approval studies (Phase 4)Looking for participantsNCT04647227
What this trial is testing

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network 55
Large-scale testing (Phase 3)Active Not RecruitingNCT05135559
What this trial is testing

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Who this might be right for
Haemophilia A and B With and Without Inhibitors
Novo Nordisk A/S 153
Post-approval studies (Phase 4)Study completedNCT01561391
What this trial is testing

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 36
Large-scale testing (Phase 3)Study completedNCT02020369
What this trial is testing

Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
rEVO Biologics 27
Large-scale testing (Phase 3)Ended earlyNCT02484638
What this trial is testing

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
CSL Behring 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Looking for participantsNCT07285460
What this trial is testing

Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

Who this might be right for
Hemophilia
Sanofi 85
Large-scale testing (Phase 3)Active Not RecruitingNCT03754790
What this trial is testing

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 281
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Testing effectiveness (Phase 2)Study completedNCT03363321
What this trial is testing

PF-06741086 Long-term Treatment in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Testing effectiveness (Phase 2)Study completedNCT02974855
What this trial is testing

PF-06741086 Multiple Dose Study in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 27
Large-scale testing (Phase 3)Active Not RecruitingNCT06569108
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Who this might be right for
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Suzhou Alphamab Co., Ltd. 125
Load More Results